BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17252985)

  • 1. [The role of melanocortin peptides in the cardiovascular regulation in haemorrhagic shock].
    Jochem J; Pierścieńiski T; Ośko A; Zwirsika-Korczala K
    Folia Med Cracov; 2005; 46(3-4):13-21. PubMed ID: 17252985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanocortins and cardiovascular regulation.
    Versteeg DH; Van Bergen P; Adan RA; De Wildt DJ
    Eur J Pharmacol; 1998 Oct; 360(1):1-14. PubMed ID: 9845266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular effects of centrally acting orexin A in haemorrhage-shocked rats.
    Jochem J; Zwirska-Korczala K; Zabielski R; Kato I; Kuwahara A
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 11():115-24. PubMed ID: 17244943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour necrosis factor-alpha as a target of melanocortins in haemorrhagic shock, in the anaesthetized rat.
    Altavilla D; Cainazzo MM; Squadrito F; Guarini S; Bertolini A; Bazzani C
    Br J Pharmacol; 1998 Aug; 124(8):1587-90. PubMed ID: 9756372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular changes induced in rat liver by hemorrhage and effects of melanocortin treatment.
    Lonati C; Sordi A; Giuliani D; Spaccapelo L; Leonardi P; Carlin A; Ottani A; Galantucci M; Grieco P; Catania A; Guarini S
    Anesthesiology; 2012 Mar; 116(3):692-700. PubMed ID: 22266570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous opioid peptides system in haemorrhagic shock--central cardiovascular regulation.
    Jochem J; Jośko J; Gwóźdź B
    Med Sci Monit; 2001; 7(3):545-9. PubMed ID: 11386040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of proopiomenalocortin-derived peptides in endogenous central histamine-induced reversal of critical haemorrhagic hypotension in rats.
    Jochem J
    J Physiol Pharmacol; 2004 Mar; 55(1 Pt 1):57-71. PubMed ID: 15082867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular and renal actions of melanocyte-stimulating hormone peptides.
    Humphreys MH
    Curr Opin Nephrol Hypertens; 2007 Jan; 16(1):32-8. PubMed ID: 17143069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the histaminergic system in the central cardiovascular regulation in haemorrhagic hypotension.
    Jochem J; Kasperska-Zajac A
    Folia Med Cracov; 2012; 52(3-4):31-41. PubMed ID: 24852685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the cholinergic system in the central histamine-induced reversal of critical haemorrhagic hypotension in rats.
    Yalcin M; Savci V; Jochem J
    J Physiol Pharmacol; 2009 Jun; 60(2):133-7. PubMed ID: 19617656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrine mechanisms during reversible hypovolaemic shock in humans with emphasis on the histaminergic and serotonergic system.
    Matzen SH
    Acta Physiol Scand Suppl; 1995; 628():1-31. PubMed ID: 8801774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective melanocortin MC4 receptor agonists reverse haemorrhagic shock and prevent multiple organ damage.
    Giuliani D; Mioni C; Bazzani C; Zaffe D; Botticelli AR; Capolongo S; Sabba A; Galantucci M; Iannone A; Grieco P; Novellino E; Colombo G; Tomasi A; Catania A; Guarini S
    Br J Pharmacol; 2007 Mar; 150(5):595-603. PubMed ID: 17245369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Melanocortin system].
    Levitskaia NG; Kamenskiĭ AA
    Usp Fiziol Nauk; 2009; 40(1):44-65. PubMed ID: 19326848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone changes and beta-endorphin in the pathogenesis of hemorrhagic shock.
    Machuganska A; Zaharieva S
    Acta Physiol Pharmacol Bulg; 1985; 11(1):26-33. PubMed ID: 2930996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that melanocortin 4 receptor mediates hemorrhagic shock reversal caused by melanocortin peptides.
    Guarini S; Bazzani C; Cainazzo MM; Mioni C; Ferrazza G; Vergoni AV; Schiöth HB; Wikberg JE; Bertolini A
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1023-7. PubMed ID: 10565820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proopiomelanocortin (POMC) products in the central regulation of sympathetic and cardiovascular dynamics: studies on melanocortin and opioid interactions.
    Dunbar JC; Lu H
    Peptides; 2000 Feb; 21(2):211-7. PubMed ID: 10764947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The differential influences of melanocortins on nociception in the formalin and tail flick tests.
    Zvejniece L; Muceniece R; Krigere L; Dambrova M; Klusa VZ
    Pharmacol Biochem Behav; 2006 Oct; 85(2):287-91. PubMed ID: 16970983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the histaminergic system in the resuscitating effect of centrally acting leptin in haemorrhagic shock in rats.
    Jochem J; Altinbas B; Yalcin M; Ottani A; Giuliani D; Savci V; Kasperska-Zajac A; Guarini S
    J Physiol Pharmacol; 2016 Feb; 67(1):67-74. PubMed ID: 27010896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain effects of melanocortins.
    Bertolini A; Tacchi R; Vergoni AV
    Pharmacol Res; 2009 Jan; 59(1):13-47. PubMed ID: 18996199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Centrally acting leptin induces a resuscitating effect in haemorrhagic shock in rats.
    Jochem J; Kalarus Z; Spaccapelo L; Canalini F; Ottani A; Giuliani D; Guarini S
    Regul Pept; 2012 Jun; 176(1-3):45-50. PubMed ID: 22465165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.